rs56270948

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_000719.7(CACNA1C):​c.5649G>A​(p.Pro1883Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0199 in 1,556,064 control chromosomes in the GnomAD database, including 345 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. P1883P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.017 ( 34 hom., cov: 32)
Exomes 𝑓: 0.020 ( 311 hom. )

Consequence

CACNA1C
NM_000719.7 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -0.308

Publications

16 publications found
Variant links:
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
ITFG2-AS1 (HGNC:53128): (ITFG2 antisense RNA 1)
CACNA1C-AS1 (HGNC:40119): (CACNA1C antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
BP6
Variant 12-2685811-G-A is Benign according to our data. Variant chr12-2685811-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 93416.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.308 with no splicing effect.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.0167 (2485/148444) while in subpopulation EAS AF = 0.0384 (198/5154). AF 95% confidence interval is 0.034. There are 34 homozygotes in GnomAd4. There are 1210 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 2485 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1CNM_000719.7 linkc.5649G>A p.Pro1883Pro synonymous_variant Exon 44 of 47 ENST00000399655.6 NP_000710.5 Q13936-12
CACNA1CNM_001167623.2 linkc.5649G>A p.Pro1883Pro synonymous_variant Exon 44 of 47 ENST00000399603.6 NP_001161095.1 Q13936-37

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1CENST00000399603.6 linkc.5649G>A p.Pro1883Pro synonymous_variant Exon 44 of 47 5 NM_001167623.2 ENSP00000382512.1 Q13936-37
CACNA1CENST00000399655.6 linkc.5649G>A p.Pro1883Pro synonymous_variant Exon 44 of 47 1 NM_000719.7 ENSP00000382563.1 Q13936-12
CACNA1CENST00000682544.1 linkc.5988G>A p.Pro1996Pro synonymous_variant Exon 47 of 50 ENSP00000507184.1 A0A804HIR0
CACNA1CENST00000406454.8 linkc.5862G>A p.Pro1954Pro synonymous_variant Exon 45 of 48 5 ENSP00000385896.3 F5GY28
CACNA1CENST00000399634.6 linkc.5829G>A p.Pro1943Pro synonymous_variant Exon 44 of 47 5 ENSP00000382542.2 E9PDI6
CACNA1CENST00000683824.1 linkc.5814G>A p.Pro1938Pro synonymous_variant Exon 45 of 48 ENSP00000507867.1 A0A804HKC4
CACNA1CENST00000347598.9 linkc.5793G>A p.Pro1931Pro synonymous_variant Exon 46 of 49 1 ENSP00000266376.6 Q13936-11
CACNA1CENST00000344100.7 linkc.5772G>A p.Pro1924Pro synonymous_variant Exon 44 of 47 1 ENSP00000341092.3 Q13936-14
CACNA1CENST00000327702.12 linkc.5754G>A p.Pro1918Pro synonymous_variant Exon 45 of 48 1 ENSP00000329877.7 A0A0A0MR67
CACNA1CENST00000399617.6 linkc.5754G>A p.Pro1918Pro synonymous_variant Exon 45 of 48 5 ENSP00000382526.1 A0A0A0MSA1
CACNA1CENST00000682462.1 linkc.5739G>A p.Pro1913Pro synonymous_variant Exon 44 of 47 ENSP00000507105.1 A0A804HIJ8
CACNA1CENST00000683781.1 linkc.5739G>A p.Pro1913Pro synonymous_variant Exon 44 of 47 ENSP00000507434.1 A0A804HJB6
CACNA1CENST00000683840.1 linkc.5739G>A p.Pro1913Pro synonymous_variant Exon 44 of 47 ENSP00000507612.1 A0A804HJR1
CACNA1CENST00000683956.1 linkc.5739G>A p.Pro1913Pro synonymous_variant Exon 44 of 47 ENSP00000506882.1 A0A804HI37
CACNA1CENST00000399638.5 linkc.5733G>A p.Pro1911Pro synonymous_variant Exon 45 of 48 1 ENSP00000382547.1 Q13936-31
CACNA1CENST00000335762.10 linkc.5724G>A p.Pro1908Pro synonymous_variant Exon 45 of 48 5 ENSP00000336982.5 F5H522
CACNA1CENST00000399606.5 linkc.5709G>A p.Pro1903Pro synonymous_variant Exon 45 of 48 1 ENSP00000382515.1 Q13936-30
CACNA1CENST00000399621.5 linkc.5706G>A p.Pro1902Pro synonymous_variant Exon 44 of 47 1 ENSP00000382530.1 Q13936-24
CACNA1CENST00000399637.5 linkc.5706G>A p.Pro1902Pro synonymous_variant Exon 44 of 47 1 ENSP00000382546.1 Q13936-27
CACNA1CENST00000402845.7 linkc.5706G>A p.Pro1902Pro synonymous_variant Exon 44 of 47 1 ENSP00000385724.3 Q13936-13
CACNA1CENST00000399629.5 linkc.5700G>A p.Pro1900Pro synonymous_variant Exon 44 of 47 1 ENSP00000382537.1 Q13936-32
CACNA1CENST00000682336.1 linkc.5691G>A p.Pro1897Pro synonymous_variant Exon 44 of 47 ENSP00000507898.1 A0A804HKE9
CACNA1CENST00000399591.5 linkc.5673G>A p.Pro1891Pro synonymous_variant Exon 43 of 46 1 ENSP00000382500.1 Q13936-29
CACNA1CENST00000399595.5 linkc.5673G>A p.Pro1891Pro synonymous_variant Exon 43 of 46 1 ENSP00000382504.1 Q13936-25
CACNA1CENST00000399649.5 linkc.5667G>A p.Pro1889Pro synonymous_variant Exon 43 of 46 1 ENSP00000382557.1 Q13936-15
CACNA1CENST00000399597.5 linkc.5649G>A p.Pro1883Pro synonymous_variant Exon 44 of 47 1 ENSP00000382506.1 Q13936-22
CACNA1CENST00000399601.5 linkc.5649G>A p.Pro1883Pro synonymous_variant Exon 44 of 47 1 ENSP00000382510.1 Q13936-20
CACNA1CENST00000399641.6 linkc.5649G>A p.Pro1883Pro synonymous_variant Exon 44 of 47 1 ENSP00000382549.1 Q13936-23
CACNA1CENST00000399644.5 linkc.5649G>A p.Pro1883Pro synonymous_variant Exon 44 of 47 1 ENSP00000382552.1 Q13936-21
CACNA1CENST00000682835.1 linkc.5649G>A p.Pro1883Pro synonymous_variant Exon 44 of 47 ENSP00000507282.1 A0A804HIZ0
CACNA1CENST00000683482.1 linkc.5640G>A p.Pro1880Pro synonymous_variant Exon 44 of 47 ENSP00000507169.1 Q13936-35
CACNA1CENST00000682686.1 linkc.5616G>A p.Pro1872Pro synonymous_variant Exon 43 of 46 ENSP00000507309.1 Q13936-19

Frequencies

GnomAD3 genomes
AF:
0.0168
AC:
2488
AN:
148338
Hom.:
34
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00935
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0108
Gnomad ASJ
AF:
0.0245
Gnomad EAS
AF:
0.0385
Gnomad SAS
AF:
0.00610
Gnomad FIN
AF:
0.0268
Gnomad MID
AF:
0.0129
Gnomad NFE
AF:
0.0199
Gnomad OTH
AF:
0.0147
GnomAD2 exomes
AF:
0.0207
AC:
4973
AN:
239870
AF XY:
0.0197
show subpopulations
Gnomad AFR exome
AF:
0.0226
Gnomad AMR exome
AF:
0.00914
Gnomad ASJ exome
AF:
0.0238
Gnomad EAS exome
AF:
0.0410
Gnomad FIN exome
AF:
0.0272
Gnomad NFE exome
AF:
0.0236
Gnomad OTH exome
AF:
0.0216
GnomAD4 exome
AF:
0.0203
AC:
28550
AN:
1407620
Hom.:
311
Cov.:
31
AF XY:
0.0196
AC XY:
13755
AN XY:
701650
show subpopulations
African (AFR)
AF:
0.0210
AC:
642
AN:
30530
American (AMR)
AF:
0.00894
AC:
387
AN:
43266
Ashkenazi Jewish (ASJ)
AF:
0.0238
AC:
602
AN:
25332
East Asian (EAS)
AF:
0.0278
AC:
1095
AN:
39362
South Asian (SAS)
AF:
0.00479
AC:
406
AN:
84770
European-Finnish (FIN)
AF:
0.0262
AC:
1380
AN:
52734
Middle Eastern (MID)
AF:
0.0163
AC:
90
AN:
5538
European-Non Finnish (NFE)
AF:
0.0213
AC:
22768
AN:
1067774
Other (OTH)
AF:
0.0202
AC:
1180
AN:
58314
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.439
Heterozygous variant carriers
0
1206
2412
3617
4823
6029
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
900
1800
2700
3600
4500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0167
AC:
2485
AN:
148444
Hom.:
34
Cov.:
32
AF XY:
0.0167
AC XY:
1210
AN XY:
72510
show subpopulations
African (AFR)
AF:
0.00932
AC:
367
AN:
39380
American (AMR)
AF:
0.0108
AC:
162
AN:
15050
Ashkenazi Jewish (ASJ)
AF:
0.0245
AC:
84
AN:
3430
East Asian (EAS)
AF:
0.0384
AC:
198
AN:
5154
South Asian (SAS)
AF:
0.00589
AC:
28
AN:
4752
European-Finnish (FIN)
AF:
0.0268
AC:
278
AN:
10376
Middle Eastern (MID)
AF:
0.0139
AC:
4
AN:
288
European-Non Finnish (NFE)
AF:
0.0199
AC:
1334
AN:
67050
Other (OTH)
AF:
0.0146
AC:
30
AN:
2054
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
114
228
342
456
570
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0218
Hom.:
12

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Mar 13, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

May 18, 2017
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:3
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 21, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Long QT syndrome Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Jun 26, 2015
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.63
CADD
Benign
3.8
DANN
Benign
0.87
PhyloP100
-0.31
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs56270948; hg19: chr12-2794977; COSMIC: COSV59745588; COSMIC: COSV59745588; API